| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | ANTHERA PHARMACEUTICALS I | 706,000 | 4,300,000 | 0.14% | ||
| 52 | QUINPARIO ACQUISITION CORP 2 | 400,000 | 4,112,000 | 0.13% | ||
| 53 | TERRAPIN 3 ACQUISITION CORP | 400,000 | 4,080,000 | 0.13% | ||
| 54 | EASTERLY ACQUISITION CORP | 400,000 | 4,040,000 | 0.13% | ||
| 55 | GORES HLDGS INC | 400,000 | 4,036,000 | 0.13% | ||
| 56 | BOULEVARD ACQUISITION | 400,000 | 3,988,000 | 0.13% | ||
| 57 | ELECTRUM SPL ACQUISITION COR | 400,000 | 3,952,000 | 0.12% | ||
| 58 | X21ST CENTURY FOX B | 140,000 | 3,790,000 | 0.12% | Put | |
| 59 | GP INVTS ACQUISITION COR | 350,000 | 3,465,000 | 0.11% | ||
| 60 | Turquoise Hill Resources Ltd | 1,250,000 | 3,188,000 | 0.10% | ||
| 61 | HYDRA INDS ACQUISITION CORP | 300,000 | 3,075,000 | 0.10% | ||
| 62 | DOUBLE EAGLE ACQUISITION COR | 300,000 | 3,042,000 | 0.10% | ||
| 63 | ONCOTHYREON INC COM N/C EFF 6/ | 1,106,000 | 3,030,000 | 0.10% | ||
| 64 | CLIFTON BANCORP INC COM | 213,452 | 2,963,000 | 0.09% | ||
| 65 | CHEMOCENTRYX INC | 482,000 | 2,916,000 | 0.09% | ||
| 66 | LIBERTY GLOBAL PLC LILAC SHS CL A | 82,800 | 2,790,000 | 0.09% | ||
| 67 | REPROS THERAPEUTICS INC | 304,000 | 2,259,000 | 0.07% | ||
| 68 | TETRAPHASE PHARMACEUTICALS I COM | 300,000 | 2,238,000 | 0.07% | ||
| 69 | AVALANCHE BIOTECHNOLOGIES IN | 260,000 | 2,142,000 | 0.07% | ||
| 70 | CENVEO INC | 1,100,000 | 2,068,000 | 0.07% | ||
| 71 | PACE HLDGS CORP | 200,000 | 2,040,000 | 0.06% | ||
| 72 | QLT INC | 765,000 | 2,035,000 | 0.06% | ||
| 73 | FAIRPOINT COMMUNICATIONS INC COM NEW | 130,000 | 2,003,000 | 0.06% | ||
| 74 | AVEO PHARMACEUTICALS INC | 1,563,827 | 1,892,000 | 0.06% | ||
| 75 | KINDRED BIOSCIENCES INC | 330,000 | 1,716,000 | 0.05% | ||
| 76 | KINDER MORGAN INCORPORATED DEL WARRANT EXP 052517 | 1,350,000 | 1,242,000 | 0.04% | ||
| 77 | SANOFI CONTGNT VAL RT | 5,500,000 | 1,047,000 | 0.03% | ||
| 78 | KERYX BIOPHARMACEUTICALS INCORPORATED | 288,000 | 1,014,000 | 0.03% | ||
| 79 | SOPHIRIS BIO INC | 538,000 | 457,000 | 0.01% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001085146-15-002358, filed 2015.11.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
